New England Independent Review Board Joins the WIRB-Copernicus Group
WIRB-Copernicus Group announced that New England Independent Review Board has joined its group of companies.
WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services for clinical research, announced that New England Independent Review Board (IRB) has joined its group of companies. Based near Boston, MA, New England IRB expands WCG’s presence in the important New England clinical research hub and further increases its expertise in all phases of drug, medical device and behavioral research. Founded in 1988, New England IRB was one of the first national, central IRBs dedicated to ensuring the rights and welfare of research study participants.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
